Human Papillomavirus in Brazilian women with and without cervical lesions

Virology Journal

Volumn 8, Issue , 2011, Pages

  Oliveira Silva, Michelle ^a   Lordello, Camila X ^b,c   Zardo, Lucília Mg ^c   Bonvicino, Cibele R ^a,c   Moreira, Miguel Am ^c  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c Instituto Nacional de Cncer   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BETAPAPILLOMAVIRUS; BRAZIL; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 66; MAJOR CLINICAL STUDY; MICROBIAL DIVERSITY; NONHUMAN; NUCLEOTIDE SEQUENCE; UTERINE CERVIX CANCER; UTERINE CERVIX DYSPLASIA; VIRUS STRAIN; WART VIRUS; ADULT; CASE CONTROL STUDY; CLASSIFICATION; GENETIC VARIABILITY; GENETICS; MIDDLE AGED; MOLECULAR GENETICS; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; PATHOLOGY; PREGNANCY; SOCIOECONOMICS; UTERINE CERVIX; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VIROLOGY;

BETAPAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS;

ADULT; BRAZIL; CASE-CONTROL STUDIES; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; FEMALE; GENETIC VARIATION; HUMANS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREGNANCY; SOCIOECONOMIC FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 78650779662     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-4     Document Type: Article

References (45)

1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. J Ferlay HR Shin F Bray D Forman C Mathers DM Parkin, Int J Cancer 2010 127 2893 2917 10.1002/ijc.25516
2. The causal relation between human papillomavirus and cervical cancer. FX Bosch A Lorincz N Munoz CJ Meijer KV Shah, J Clin Pathol 2002 55 244 265 11919208 (Pubitemid 34293391)
3. Papillomaviruses and cancer: from basic studies to clinical application. H zur Hausen, Nat Rev Cancer 2002 2 342 350 10.1038/nrc798 12044010
4. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. JM Walboomers MV Jacobs MM Manos FX Bosch JA Kummer KV Shah PJ Snijders J Peto CJ Meijer N Munoz, J Pathol 1999 189 12 19 10.1002/(SICI)1096- 9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F 10451482
5. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Mũoz FX Bosch S de Sanjose R Herrero X Castellsague KV Shah PJ Snijders CJ Meijer, N Engl J Med 2003 348 518 527 12571259 (Pubitemid 36159887)
6. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. JS Smith L Lindsay B Hoots J Keys S Franceschi R Winer GM Clifford, Int J Cancer 2007 121 621 632 10.1002/ijc.22527 17405118
7. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. GM Clifford S Gallus R Herrero N Munoz PJ Snijders S Vaccarella PT Anh C Ferreccio NT Hieu E Matos, et al. Lancet 2005 366 991 998 10.1016/S0140-6736(05)67069-9 16168781
8. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. S de Sanjose M Diaz X Castellsague G Clifford L Bruni N Munoz FX Bosch, Lancet Infect Dis 2007 7 453 459 10.1016/S1473-3099(07)70158-5 17597569
9. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. DM Harper EL Franco C Wheeler DG Ferris D Jenkins A Schuind T Zahaf B Innis P Naud NS De Carvalho, et al. Lancet 2004 364 1757 1765 10.1016/S0140-6736(04)17398-4 15541448
10. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. LL Villa RL Costa CA Petta RP Andrade KA Ault AR Giuliano CM Wheeler LA Koutsky C Malm M Lehtinen, et al. Lancet Oncol 2005 6 271 278 10.1016/S1470-2045(05)70101-7 15863374
11. Human papillomavirus genotypes in rural Mozambique. X Castellsague C Menendez MP Loscertales JR Kornegay F dos Santos FX Gomez-Olive B Lloveras N Abarca N Vaz A Barreto, et al. Lancet 2001 358 1429 1430 10.1016/S0140-6736(01) 06523-0 11705494
12. Human papillomavirus genotypes in cervical cancers in Mozambique. P Naucler FM Da Costa O Ljungberg A Bugalho J Dillner, J Gen Virol 2004 85 2189 2190 10.1099/vir.0.80001-0 15269357
13. Human papillomavirus type distribution in women from Asia: a meta-analysis. YP Bao N Li JS Smith YL Qiao, Int J Gynecol Cancer 2008 18 71 79 10.1111/j.1525-1438.2007.00959.x 17466054
14. Prevalence of human papillomavirus types in women with pre-neoplastic and neoplastic cervical lesions in the Federal District of Brazil. GN Camara DM Cerqueira AP Oliveira EO Silva LG Carvalho CR Martins, Mem Inst Oswaldo Cruz 2003 98 879 883 10.1590/S0074-02762003000700003 14762511
15. Prevalence, distribution and correlates of endocervical human papillomavirus types in Brazilian women. SA Lippman MC Sucupira HE Jones CG Luppi J Palefsky JH van de Wijgert RL Oliveira RS Diaz, Int J STD AIDS 2010 21 105 109 10.1258/ijsa.2009.008436 20089995
16. Prevalence of human papillomavirus in archival samples obtained from patients with cervical pre-malignant and malignant lesions from Northeast Brazil. JV Fernandes RV Meissner MG Carvalho TA Fernandes PR Azevedo JS Sobrinho JC Prado LL Villa, BMC Res Notes 2010 3 96 10.1186/1756-0500-3-96 20377903
17. High prevalence of human papillomavirus type 58 in patients with cervical pre-malignant lesions in southern Brazil. S Paesi EP Serafini F Barea SR Madi S Echeverrigaray, J Med Virol 2009 81 1270 1275 10.1002/jmv.21410 19475616
18. Human papillomavirus prevalence among women with cervical intraepithelial neoplasia III and invasive cervical cancer from Goiania, Brazil. SH Rabelo-Santos L Zeferino LL Villa JP Sobrinho RG Amaral AV Magalhaes, Mem Inst Oswaldo Cruz 2003 98 181 184 10.1590/S0074-02762003000200003 12764431
19. Human papillomavirus genotypes in asymptomatic young women from public schools in Rio de Janeiro, Brazil. LH Oliveira MD Ferreira EF Augusto FG Melgaco LS Santos SM Cavalcanti ML Rosa, Rev Soc Bras Med Trop 2010 43 4 8 20305959
20. HPV31 and HPV33 incidence in cervical samples from women in Recife, Brazil. MF Baldez da Silva BS Chagas V Guimaraes LM Katz PM Felix PM Miranda AA Lima LC Arraes DB Martins JL Lima Filho, et al. Genet Mol Res 2009 8 1437 1443 10.4238/vol8-4gmr677 20013657
21. Transmission of cervical human papillomavirus infection by sexual activity: differences between low and high oncogenic risk types. EL Franco LL Villa A Ruiz MC Costa, J Infect Dis 1995 172 756 763 7658069
22. The use of human papillomavirus typing in detection of cervical neoplasia in Recife (Brazil). F Lorenzato L Ho G Terry A Singer LC Santos R De Lucena Batista T Lubambo, Int J Gynecol Cancer 2000 10 143 150 10.1046/j.1525-1438. 2000.00007.x 11240666
23. Persistence and clearance of human papillomavirus infection: a prospective cohort study. MI Rosa JM Fachel DD Rosa LR Medeiros CN Igansi MC Bozzetti, Am J Obstet Gynecol 2008 199 617 e611 617 10.1016/j.ajog.2008.06.033
24. HPV detection and genotyping as an earlier approach in cervical cancer screening of the female genital tract. WM Krambeck RM Cadide EM Dalmarco CM de Cordova, Clin Exp Obstet Gynecol 2008 35 175 178 18754286
25. Cervical HPV infection in Brazil: systematic review. AR Ayres G Azevedo e Silva, Rev Saude Publica 2010 44 963 974 20877926
26. Comparison of human papillomavirus detection and typing by cycle sequencing, line blotting, and hybrid capture. SD Vernon ER Unger D Williams, J Clin Microbiol 2000 38 651 655 10655362
27. A large case-control study of cervical cancer risk associated with human papillomavirus infection in Japan, by nucleotide sequencing-based genotyping. T Asato T Maehama Y Nagai K Kanazawa H Uezato K Kariya, J Infect Dis 2004 189 1829 1832 10.1086/382896 15122519
28. Validation of human papillomavirus genotyping by signature DNA sequence analysis. SH Lee VS Vigliotti JS Vigliotti S Pappu, BMC Clin Pathol 2009 9 3 10.1186/1472-6890-9-3 19463165
29. Prevalence and type distribution of human papillomavirus in 5,000 British Columbia women - implications for vaccination. RA Moore G Ogilvie D Fornika V Moravan M Brisson M Amirabbasi-Beik A Kollar T Burgess R Hsu L Towers, et al. Cancer Causes Control 2009 20 1387 1396 10.1007/s10552-009-9365-4 19475481
30. Prevalence of various human papillomavirus (HPV) genotypes among women who subjected to routine Pap smear test in Bushehr city (south west of Iran) 2008-2009. K Zandi SS Eghbali R Hamkar S Ahmadi E Ramedani I Deilami HA Nejad F Farshadpour Z Rastian, Virol J 2010 7 65 10.1186/1743-422X-7-65 20302680
31. Evaluation of agreement between conventional and liquid-based cytology in cervical cancer early detection based on analysis of 2,091 smears: experience at the Brazilian National Cancer Institute. VR Girianelli LC Santos Thuler, Diagn Cytopathol 2007 35 545 549 10.1002/dc.20699 17703446
32. Comparison of human papillomavirus DNA tests, liquid-based cytology and conventional cytology for the early detection of cervix uteri cancer. VR Girianelli LC Thuler M Szklo A Donato LM Zardo JA Lozana OF Almeida Neto AC Carvalho JH Matos V Figueiredo, Eur J Cancer Prev 2006 15 504 510 10.1097/01.cej.0000220630.08352.7a 17106330
33. Quality of cervical cancer data system in the state of Rio de Janeiro, Southeastern Brazil. VR Girianelli LC Thuler GA Silva, Rev Saude Publica 2009 43 580 588 10.1590/S0034-89102009005000043 19618027
34. RJ Kurman D Solomon, The Bethesda System for reporting cervical/vaginal cytologic diagnoses New York 1994
35. The use of polymerase chain reaction amplification for the detection of genital human papillomavirus. MMT Manos DK Wright AJ Lewis TR Broker SM Wolinsky, Cancer Cell Mol Diagnost Hum Cancer 1989 7 209 214
36. The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. AM de Roda Husman JM Walboomers AJ van den Brule CJ Meijer PJ Snijders, J Gen Virol 1995 76 1057 1062 10.1099/0022-1317-76-4-1057 9049358
37. ChromaPipe: a pipeline for analysis, quality control and management for a DNA sequencing facility. TD Otto EA Vasconcellos LH Gomes AS Moreira WM Degrave L Mendonca-Lima M Alves-Ferreira, Genet Mol Res 2008 7 861 871 10.4238/vol7-3X-Meeting04 18949705
38. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. K Tamura J Dudley M Nei S Kumar, Mol Biol Evol 2007 24 1596 1599 10.1093/molbev/msm092 17488738
39. Classification of papillomaviruses. EM de Villiers C Fauquet TR Broker HU Bernard H zur Hausen, Virology 2004 324 17 27 10.1016/j.virol.2004.03.033 15183049
40. High prevalence of a variety of epidermodysplasia verruciformis- associated human papillomaviruses in psoriatic skin of patients treated or not treated with PUVA. SJ Weissenborn R Hopfl F Weber H Smola HJ Pfister PG Fuchs, J Invest Dermatol 1999 113 122 126 10.1046/j.1523-1747.1999.00641.x 10417630
41. Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types. PE Castle M Schiffman RD Burk S Wacholder A Hildesheim R Herrero MC Bratti ME Sherman A Lorincz, Cancer Epidemiol Biomarkers Prev 2002 11 1394 1399 12433717 (Pubitemid 35340375)
42. Human papillomavirus genotype specificity of hybrid capture 2. PE Castle D Solomon CM Wheeler PE Gravitt S Wacholder M Schiffman, J Clin Microbiol 2008 46 2595 2604 10.1128/JCM.00824-08 18579716
43. Efficiency of the hybrid capture 2 HPV DNA test in cervical cancer screening. A study by the French Society of Clinical Cytology. P de Cremoux J Coste X Sastre-Garau M Thioux C Bouillac S Labbe I Cartier M Ziol A Dosda C Le Gales, et al. Am J Clin Pathol 2003 120 492 499 10.1309/XFUCPP6M5XUA94B8 14560561
44. Human papillomavirus genotype specificity of hybrid capture 2 low-risk probe cocktail. M Poljak BJ Kocjan A Kovanda MM Lunar SZ Lepej A Planinic K Seme A Vince, J Clin Microbiol 2009 47 2611 2615 10.1128/JCM.00278-09 19494080
45. Hybrid Capture II HPV Test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail. M Poljak IJ Marin K Seme A Vince, J Clin Virol 2002 25 89 97 10.1016/S1386-6532(02)00187-7 12467782